Here, we demonstrate that targeted disruption of the essential autophagy gene ATG5 metabolically reprograms αFR CAR-T cells for improved function under immune-suppressive conditions, leading to sustained rejection of ovarian tumors in vivo. Here, ATG5 is linked to ovarian neoplasm.